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Abstract
High speed physiological data represents one of the most
untapped resources in healthcare today and is a form of Big
Data. Physiological data is captured and displayed on a wide
range of devices in healthcare environments. Frequently this
data is transitory and lost once initially displayed.
Researchers wish to store and analyze these datasets,
however, there is little evidence of any engagement with
citizens regarding their perceptions of physiological data
capture for secondary use. This paper presents the findings of
a self-administered household survey (n=165, response rate =
34%) that investigated Australian and Canadian citizens’
perceptions of such physiological data capture and re-use.
Results indicate general public support for the secondary use
of physiological streaming data. Discussion considers the
potential application of such data in neonatal intensive care
contexts in relation to our Artemis research. Consideration of
the perceptions of secondary use of the streaming data as
early as possible will assist in building appropriate use
models, with a focus on parents in the neonatal context.
Keywords
Patient data privacy; Data collection; Medical device

Introduction
In recent research, there has been an increased interest in the
analysis of physiological data, particularly in real-time. Many
critical care and neurological monitoring applications capture
physiological data. Examples include electrocardiogram
(ECG), electroencephalogram (EEG) and pulse oximetry data
[1].
High speed physiological data represents one of the most
untapped resources in healthcare today and is a form of Big
Data. In neonatal intensive care for example, a premature
newborn infant’s heart beats approximately 7000 times an
hour and yet traditional charting on paper, or within an
electronic health record (EHR), includes one number per hour
of an indicative heart rate for that hour. The heuristics
employed to determine the number to write are as much
qualitative as quantitative and part of the function is to express
overall stability or instability hour to hour. The potential for
the use of high speed physiological data for earlier and
potentially more reliable pathophysiological indicators have
been presented for late onset neonatal sepsis [2],
pneumothorax [3], intraventricular haemorrhage [4, 5] and
periventricular leukomalacia [6]. Opportunities abound for the
exploration of new pathophysiological indicators for many
other conditions, but these are yet to be explored due to the
absence of a collection of physiological data for patients

developing such conditions. Analytics on high frequency
physiological data, from both the perspective of retrospective
knowledge discovery and real-time monitoring has the
potential to be equally disruptive for healthcare as genomics
research.
Within the Neonatal Intensive Care Unit (NICU), a variety of
medical devices monitor the infant’s vital organs while other
equipment assist with breathing, maintains appropriate body
temperature and provides necessary drugs and nutrients. Many
of these devices continuously create physiological data
second-by-second. Although many health care settings are in
the process of transitioning from the use of paper to electronic
for charting purposes, this does not include new approaches
for new analytics derived from this sensor data. This leads
health care professionals to rely on sharing clinical
information in a qualitative manner [7]. Comparable to the
concept of business intelligence and analytics, which stems
from the prompt interpretation of large volumes of data for
actionable information, there is a growing urgency for the
health care sector to similarly adopt a notion of “health care
intelligence” in (near) real-time [1]. There are limitations
regarding the use of analytics in health care due to the time it
takes to deliver predictions to healthcare providers and enable
action [8].
The value of Big Data comes from the ability to make
“connections between pieces of data, about an individual,
about individuals in relation to others, about groups of people,
or simply about the structure of information itself” [9]. An
example of a Big Data platform that includes the use of
physiological streaming data is Artemis. Artemis supports
online health analytics that allows for concurrent multipatient, multi-diagnosis and multi-stream temporal analysis of
complex, high-frequency physiological data streams in realtime for purposes of clinical management and research. By
comparing the analytical results that are gathered in the
platform with current treatment practices, new patterns in realtime physiological data can be discovered, thus enabling
earlier detection and possible prevention of various health
conditions before clinical symptoms are visible. Artemis
captures ECG data and ECG derived signals including the
heart rate, respiration rate and chest impedance for purposes of
breath detection. Other signals captured include blood oxygen
saturation in addition to diastolic, systolic and mean blood
pressure when such data is available [7].
Secondary usage of health data is defined as the use of
personal health information collected for purposes unrelated to
the initial purpose of providing direct delivery of health care
to the patient/data subject. This includes activities such as
research, analysis, quality and safety measurement, payment,
provider accreditation and commercial activities [10]. The
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secondary usage of personal health data plays an essential ro
ole
in expanding current knowledge and understanding of health
care and its delivery. Utilitarian motivations are strong in this
research area, however, less utilitarian and more commercial
focused and personally confrontin
ng issues are also significant.
Privacy issues in this area are well documented and
challenging [11-13]. Physiological data (e.g. ECG data) has
the potential to reveal more information about an individual
than what may be realized on first consideration. Nonetheless,
it appears that many people are still willing to contribute the
use of physiological data generated by themselves or even by
their neonate(s) as a resource for the advancement of health
research. Suitable privacy and governance frameworks are
required in this fast moving domain. The potential for
secondary use of physiological streaming data is clear and it is
important for us to begin to understand what the public
opinion is regarding the secondary use of their health data,
specifically physiological data for health research purposes.
The remainder of this paper is structured as follows: The
survey of Australian and Canadian citizens will be introduced
and results pertaining to secondary use of data captured
through physiological devices will be reported. This section is
followed by a discussion about related work regarding
neonatal contexts and associated issues surrounding the use of
Big Data in health care. Prior research regarding parental
attitudes towards research in the neonatal population and
privacy concerns will be considered. Conclusions and future
research are then presented.

displayed on the screen to be saved in an anonymous way and
used for medical research purposes.
The stimulus statement used to capture feedback on
ph
hysiological devices makes it clear that the data will be
anonymized and used only for medical research purposes.
Results for both Australians and Canadians indicate agreement
with this type of secondary use of streaming data.

Figure 1- Frequency responses to Statement 26
on Australian surveys

Materials and Methods
The opinion of patients regarding the possibility of analytics
on physiological data was explored, as part of a larger study,
through a pilot survey deployed in Australia and Canada in
2009. The pilot survey included thirty attitudinal statements
using a seven point Likert scale for responses and two openended questions. Focus groups reviewed the survey design
before deployment. These groups included teenagers, aged
pensioners, early school leavers, postgraduates and citizens
with English as a second langu
g age. Between August and
November, 482 self-administered surveys were distributed to
residential blocks in regional New South Wales (NSW) and
Darwin. During October and November, 250 surveys were
distributed to sample populations in Ontario. The survey
sampling strategy included high, medium and low socioeconomic populations in regional and urban areas. Cronbach’s
Alpha results for reliability were in the acceptable range.
Ethics approval was provided by the Research Ethics Board at
the University of Ontario Institute of Technology and the
Human Research Ethics Committee of the University of
Wollongong.
The broader study that these questions are drawn from
explored general public expectations and concerns regarding
secondary use of their medical data, particularly pertaining to
privacy matters [14, 15]. Constructs in the survey investigated
the con
ncepts underpinning the contemporary privacy theories
of Restricted Access and Limited Control (RALC) [16] and a
proposed framework for contextual integrity [17].

Results
The Australian and Canadian pilot surveys achieved response
rates of 34.8% and 21.5% respectively. Question 26 in the
survey explored the reuse of data captured through
physiological devices: If I was in hospital and a medical
device was used to care for me – like a heart monitor or
oxygen saturation monitor – I would agree for the information

Figure 2- Frequency responses to Statement 26
on Canadian surveys

Discussion
The discussion
o here considers the secondary use of
ph
hysiological streaming data within the neonatal intensive
care context. It has been demonstrated that many parents are
veery willing to enroll their neonate in research studies [18, 19]
even if it is known that there are significant gaps in knowledge
about the study [18]. Many parents would also be willing to
enroll their neonate again, if presented with the opportunity
[18]. This is further supported by a study conducted by
Morley et al. [20]. Parental opinions regarding the enrollment
of their premature neonate(s) into several research studies in
th
he days following birth were examined via the use of a
questionnaire. Parents of preterm infants in the NICU who
were invited to participate in two or more research studies
were approached with this survey. Amongst the invited
paarticipants, 10% declined to allow their infants to jo
oin any
studies. The majority of parents were willing to have their
infant(s) be enrolled in multiple studies. In fact, 58% of the
paarents were willing to give their permission to enroll their
infant(s) in three or more studies and 20% were willing to
haave their infant(s) participate in more than ten studies [20].
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Many parents choose to consent for their neonate’s
participation in research studies because they are hopeful that
it would somehow benefit their infant [18]. Many parents also
want to contribute to the advancement of health research.
According to findings by Morley et al. [20], 94% of the
parents thought that if their baby joined a research study, the
care of infants in the future would either be “better” or “very
much better”. Parental altruism was further demonstrated
when parents were asked “Who will benefit from these
studies?” in which 91% responded that “future babies”, 67%
said “researchers”, 25% mentioned “my baby” and 2% said
“no one”. The insight provided by the Australian and
Canadian survey results suggest that perhaps parents making
decisions for neonates would also agree with the anonymised
use of physiological streaming data for research purposes.
This is an open research area where results could inform the
governance and strategy surrounding deployment of data
analytics platforms, utilizing physiological streaming data in
neonatal contexts.
The issue of well informed consent arises, particularly in
emotion charged contexts such as neonatal environments and
the next section considers these issues.
Consent in the NICU context
The practice of acquiring informed consent is a crucial
component of the research process for the protection of a
neonatal research subject [21]. For consent to be considered
valid, the following elements must be satisfied: full
comprehension, information, and voluntariness. The
participant must be mentally competent to make a free and
adequately informed decision and must give their consent
voluntarily and freely. Sufficient information, including the
risks about the decision to be made must also be provided to
the participant [22, 23].
The informed consent process is straightforward when it
comes to dealing with a competent adult [24, 25]. Obtaining
informed consent presents ethical and legal difficulties in
certain groups of people who are considered to be part of
vulnerable populations, often as a result of limited capacity or
inadequate access to social goods such as rights, opportunities
and power [26]. This includes but is not limited to minors and
individuals living with mental disabilities or diminishing
capacity [18, 22, 25, 26] as well as individuals in certain
situations when one may be unable to consent for oneself.
Proxy consent is therefore required for such groups of people
and/or in such situations. Proxy consent is the process which
occurs when individuals with the legal right to consent give
advance permission to an authorized third party who is legally
and competent to consent on their behalf when the individual
is unable to consent for themselves. This adult may be
designated through the power of attorney to consent or via a
living will [22, 26, 27]. In the case of a newborn, the proxy
consent at best represents parental discretion, preferences and
family values [22, 25] as the neonate is incapable of
communicating his/her own opinion about research and their
willingness to participate [22].
It is well understood that the information provided regarding
the details of a study should be sufficient enough for the
reasonable parent to make an informed decision. Yet striking
an ideal balance is easier said than done, since by providing
too little information can render consent invalid, whereas
providing too much information may consequently cause
unnecessary distress. In addition to the emotional stress
associated with the birth of a premature and/or critically ill
infant, the mother may also have to deal with the physical
stress related to the recovery period following the birth [22,
28]. The parents of such infants then face a multitude of
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complicated and urgent decisions while rapidly digesting new
and changing information [29] in an unfamiliar environment.
They are then obliged to take on the responsibility of being
surrogate decision-makers on behalf of their infant. With no
previous experience on which to turn, this can be a frightening
experience as these parents are concerned with trying to make
the right decision to benefit their infant or if they are unable
to, at the very least, they want to make a decision that will
benefit future infants [30].
However, it is difficult to test if parents truly understand what
they are consenting their infant to when it comes to research
studies [25]. Stenson et al. [31] conducted a survey that
examined if parents of infants who entered into a randomized
controlled trial of pulmonary function testing had any
recollections about being asked to give consent for enrolling
their infant in a research study and how they felt the research
had affected their experience as parents of a sick infant.
Although the parents were given a detailed verbal description
and printed information sheet regarding the trial, of the 99
respondents, 12% could not remember being approached for
consent and did not think that their infant had participated in a
research study and 6% remembered being approached for
consent but were unsure of whether or not their infant actually
participated in a study. 89% parents who remembered being
approached for consent felt that a full explanation of the
studies they were enrolling their infant in had been provided to
them; however only 27% and 42% of those parents felt that
they understood the explanation completely and reasonably
well respectively. The rest of the parents either understood a
little of the explanation or not at all.
Ballard et al. [18] also examined the validity of informed
consent obtained in the perinatal period in relation to their
NEOPAIN study. To determine the level of parental
understanding of the study, participating parents were asked
open-ended questions that addressed the timing of consent,
understanding of the study’s purpose, benefits and risks, the
voluntary nature of the project, and their willingness to enroll
in future studies if applicable. Of the 64 parents who were
interviewed, 5 parents (7.8%) did not remember the study or
signing of consent. Of the remaining 59 parents who
remembered the study, only 67.8% understood the study’s
purpose. It was observed that maternal understanding
regarding the purpose of the study was greater than that of
paternal understanding (73.3% vs 57.1%) which was
particularly interesting as this study also evaluated the
mother’s medication effect on their memory. The medication
given most frequently to the mothers in this study population
was magnesium sulfate, a drug that can cause adverse effects
on memory and mentation although in reality, the risks are
minimal. At the time they signed their consent to enroll their
infant in the NEOPAIN study, 37 of the 43 mothers were
being treated with magnesium sulfate but it was noted that the
administration of the drug in this case appeared to have
minimal effect on the mother’s ability to recall the study. It
was proposed that despite exposure to labor and medication,
mothers are better able to handle stress or process information
more effectively. Involving the father in the consent process
did not improve the overall understanding of the study or its
benefits and risks.
Yet even with a double consent process, in which parents
experience the consent process twice with the first time taking
place before the neonate’s birth and the second time occurring
before the neonate’s enrollment in a study, it has been found
that these parents are no more likely to have given valid
consent in comparison to those parents who consented only
once. The reasons for this phenomenon is not well understood
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although it has been suggested parental stress immediately
following birth may play a role [18].
Privacy in the NICU context
Philosopher Herman Tavani provides an insightful phrase
which is a useful starting point for considering privacy
matters: “Privacy is a concept that is neither clearly
understood nor easily defined” [32, p.11]. Within the scholarly
literature, many have attempted and continue to attempt to
provide the ideal definition of privacy. Some, such as Alpert
(2000) see privacy as having the freedom to be whom and
what one is as an individual while others such as Stephen
(1873), Warren and Brandeis (1890), Westin (1967) and
Gavison (1980) define it as “anything that offends decency”,
“being let alone”, to “control over information” and “restricted
access to persons and personal information” respectively, as
cited by Allen [33]. There are also cultural dependencies with
some cultures valuing privacy more than others [34].
Traditionally the privacy of medical patients’ personal
information has been protected through application of the
‘limited access’ theory of privacy. With the change of medium
used for capture and storage of personal medical information
from paper to electronic, the ‘limited access’ approach to
privacy is under pressure due to the ease with which electronic
information can be exchanged. This is an issue of growing
importance with the emergence of Big Data, and the
physiological streaming data available in the NICU would
benefit from consideration against more contemporary privacy
theories [16, 17] that go beyond the ‘restricted access’ or
‘limited control’ paradigms.
The NICU context, with volumes of streaming physiological
data, is well described by Nissenbaum’s definition of context:
Contexts are structured social settings characterized by
canonical activities, roles, relationships, power structures,
norms (or rules) and internal values (goals, ends, purposes)
[17, p. 132].
The survey question regarding reuse of streaming
physiological data provides context related insights. The goalends-purposes of the data reuse were clearly described as
being ‘for research purposes’. The role of the survey
respondent as a patient was clarified. The power structures
were considered with the patient given some power to make
decisions regarding the re-use of their data. The wording of
the survey question implied that the clinicians were seeking
shared power over the streaming data.
The deployment of privacy frameworks within the NICU to
explore: (1) the enhancement of consent and simultaneously
(2) privacy as contextual integrity concepts is an open
research area. The early survey results and NICU specific
matters considered here are a useful launch-point for further
work. The broader patient privacy study referenced here
explored concepts of shared power involving clinicians and
patients and results indicated there was an appetite for this
type of arrangement from both Australians and Canadians
surveyed. There is clearly a need for the development of an
appropriate patient privacy/clinician engagement model.
Biometrics from the NICU
Biometric data is considered personal information when
derived from an individual to determine or verify one’s
identity [35]. The term “biometrics” may refer to quantifiable
characteristics or the automated methods that utilize the
aforementioned characteristics to identify or confirm one’s
identity [36]. Any human behavioural and/or physiological
characteristic has the potential to be utilized as a biometric

identifier provided it satisfies the criteria of universality,
distinctiveness, acceptability, collectability, performance,
permanence and circumvention [37]. This may have
implications for the secondary use of physiological streaming
data – even when the data has been anonymized.
It is unclear how biometrics captured while an individual is a
patient in a NICU environment could be exploited later in that
individual’s life. However it is noted here that the issues
surrounding biometrics will influence the future directions of
secondary use of streaming physiological data.

Conclusion
This paper highlights the important contributions that
physiological data, as captured by Big Data platforms, brings
to health research. To date there has been little research
relating to patient engagement in matters related to secondary
use of such data. Contemporary privacy theories may aid
navigating the emerging privacy and ethical issues, including
biometrics, regarding streamlining physiological data. The
survey results presented here formed part of a broader study
into Australian and Canadian citizens opinions regarding
application of contemporary privacy theory in medical
domains. The focus here has been on the NICU context and
potential for collaboration with parents of neonates on matters
pertaining to consent, privacy and streamlining physiological
data. The Artemis platform has been considered as one Big
Data platform providing technological support.
It is important to understand the perceptions of secondary use
of data in this area as early as possible and build an
appropriate use model. The initial patient perceptions
presented here can inform the challenging privacy aspects of a
future physiological data use model. Physiological data
analysis could potentially be the path to the next major
advances in healthcare thus serving as a motivation to our
research on a parent engaged privacy model using Big Data.
Acknowledgments
This research has been funded by the Canada Research Chairs
program and received support from the Centre for CanadianAustralian Studies, University of Wollongong

References
[1] Sahoo SS, Jayapandian C, Garg G, Kaffashi F, Chung S,
Bozorgi A. Heart beats in the cloud: Distributed analysis of
electrophysiological "Big Data" using cloud computing for
epilepsy clinical research. J Am Med Inform Assoc.
2014;21(2):263-71. doi: 10.1136/amiajnl-2013-00215.
[2] McGregor C, Catley C, James A, editors. Variability
analysis with analytics applied to physiological data
streams from the neonatal intensive care unit. 25th IEEE
International Symposium on Computer-Based Medical
Systems (CBMS 2012); 2012; Rome, Italy: IEEE.
[3] McIntosh N. Clinical diagnosis of pneumothorax is late:
Use of trend data and decision support might allow
preclinical detection. Pediatr Res. 2000;48(3):408-15. doi:
10.1203/00006450-200009000-00025.
[4] Fabres J, Carlo W, Phillips V. Both extremes of arterial
carbon dioxide pressure and the magnitude of fluctuations
in arterial carbon dioxide pressure are associated with
severe intraventricular hemorrhage in preterm infants.
Pediatrics. 2007;119(2):299-305. doi: 10.1542/peds.20062434.
[5] Tuzcu V, Nas S, Ulusar U. Altered heart rhythm dynamics
in very low birth weight infants with impending

C. McGregor et al. / Streaming Physiological Data

intraventricular hemorrhage. Pediatrics. 2009;123(3):8105. doi: 10.1542/peds.2008-0253.
[6] Shankaran S, Langer J. Cumulative index of exposure to
hypocarbia and hyperoxia as risk factors for periventricular
leukomalacia in low birth weight infants. Pediatrics.
2006;118(4):1654-9. doi: 10.1542/ peds.2005-2463.
[7] McGregor C. Big data in neonatal intensive care.
Computer. 2013;46(6):54-9. doi: 10.1109/MC.2013.157.
[8] Bates DW, Saria S, Ohno-Machado L, Shah A, Escobar G.
Big data in health care: Using analytics to identify and
manage high-risk and high-cost patients. Health Affairs.
2014;33(7):1123-31. doi: 10.1377/hlthaff.2014.0041.
[9] boyd D, Crawford K. Six provocations for big data. A
Decade in Internet Time: Symposium on the Dynamics of
the Internet and Society; 21 September 2011; Oxford.
2011.
[10] Safran C, Bloomrosen M, Hammond W, Labkoff S,
Markel-Fox S, Tang P, et al. Toward a national framework
for secondary use of health data: An American medical
informatics society white paper. 2006.
[11] Lowrance W. Learning from experience: Privacy and the
secondary use of data for health research. London: The
Nuffield Trust, 2002.
[12] Willison D. Privacy and the secondary use of data for
health research: Experience in Canada and suggested
directions forward. J Health Serv Res Policy.
2003;8(supplement 1):17-23. doi:
10.1258/135581903766468837.
[13] Willison D, Steeves V, Charles C, Schwartz L, Ranford J,
Agarwal G, et al. Consent for use of personal information
for health research: Do people with potentially stigmatising
health conditions and the general public differ in their
opinions? BMC Med Ethics. 2009;10(10). doi:
10.1186/147269391010.
[14] Heath J. Emerging consumers view of secondary uses of
medical data. In: Michael K, editor. International
Symposium on Technology and Society; Piscataway, New
Jersey, USA: IEEE; 2010. p. 87-95.
[15] Heath J, Dawson L, Pearson R, editors. Consumer
perceptions of medical data ownership and sharing for
secondary use purposes. HIC Big Data 2013 Conference;
2013 18-19 April; Melbourne, Australia.
[16] Tavani H, Moor J. Privacy protection, control of
information and privacy-enghancing technologies.
SIGCAS Comput Soc. 2001;31(1):6-11. doi:
10.1145/572277.572278.
[17] Nissenbaum H. Privacy in context: Technology, policy
and the integrity of social life. Stanford, California:
Stanford University Press; 2010.
[18] Ballard H, Shook L, Desai N, Anand K. Neonatal
research and the validity of informed consent obtained in
the perinatal period. J Perinatol. 2004;24:409-15. doi:
10.1038/sj.jp.7211142.
[19] Stenson B, Becher J-C, McIntosh N. Neonatal research:
the parental perspective. Arch Dis Child Fetal Neonatal
Ed. 2004;89(4):321-4.
[20] Morley C, Lau R, Davis P, Morse C. What do parents
think about enrolling their premature babies in several
research studies? Arch Dis Child Fetal Neonatal Ed.
2005;90(3):F225–8.
[21]Burgess E, Singhal N, Amin H, McMillan DD, Devrome
H. Consent for clinical research in the neonatal intensive

457

care unit: A retrospective survey and prospective study.
Arch Dis Childhood Fetal Neonatal Ed. 2003;88(4):280-6.
[22] Mason S. Obtaining informed consent for neonatal
randomised controlled trials - an “elaborate ritual”? Arch
Dis Child Fetal Neonatal Ed. 1997;76(3):F143–5. doi:
10.1136/fn.76.3.F143.
[23] Oberle K, Singhal N, Huber J, Burgess E. Development
of an instrument to investigate parents’ perceptions of
research with newborn babies. Nurs Ethics.
2000;7(4):327–38.
[24] Committee on Bioethics American Academy of
Pediatrics. Informed consent, parental permission, and
assent in pediatric practice. Pediatrics. 1995;95(2):314–7.
[25] Cooke R. Good practice in consent. Seminars in Fetal &
Neonatal Medicine. 2005;10(1):63–71.
[26] Canadian Institutes of Health Research, Natural Sciences
and Engineering Research Council of Canada, Social
Sciences and Humanities Research Council of Canada. Tricouncil policy statement: Ethical conduct for research
involving humans. 2 ed. Ottawa, Canada. 2014.
[27] Richards E. Proxy consent 1993 [cited 2014 May 16].
Available from:
http://biotech.law.lsu.edu/Books/lbb/x302.htm.
[28] Singhal N, Oberle K, Burgess E, Huber-Okrainec J.
Parents’ perceptions of research with newborns. J
Perinatol. 2002;22(1):57–63. doi: 10.1203/00006450199904020-00214.
[29]Baker B, McGrath JM. Engaging Families in Neonatal
Research. Newborn Infant Nurs Rev. 2010;10(1):5-7. doi:
10.1053/j.nainr.2009.12.004.
[30] Golec L, Gibbins S, Dunn MS, Hebert P. Informed
consent in the NICU setting: an ethically optimal model for
research solicitation. J Perinatol. 2004;24(12):783–91. doi:
10.1038/sj.jp.7211198.
[31] Stenson B, Becher J, McIntosh N. Neonatal research: The
parental perspective. Arch Dis Child Fetal Neonatal Ed.
2004;89(4):F321-4. doi: 10.1136/adc.2002.021931.
[32] Tavani H. Privacy online. SIGCAS Comput Soc.
1999;29(4):11-9. doi: 10.1145/572199.572203.
[33] Allen A. Genetic privacy: Emerging concepts and values.
In: Rothstein MA, editor. Genetic secrets: Protecting
privacy and confidentiality in the genetic era. New Haven,
CT: Yale University Press; 1997. p. 31–59.
[34] Moor J, editor. Towards a Theory of Privacy for the
Information Age. Amherst, New York: Prometheus Books;
2000.
[35] International Biometric Group LLC. BioPrivacy FAQ’s
and definitions [updated 2010; cited 2014 Apr 8].
Available from: http://www.bioprivacy.org/.
[36] National Science Technology Council [NSTC]
Committee on Technology, Committee on Homeland and
National Security SoB. Privacy & biometrics: Building a
conceptual foundation. 2006. p. 1–57.
[37] Kannavara R, KL S. Topics in biometric human-machine
interaction security. IEEE Potentials. 2013;32(6):18–25.
doi: 10.1109/MPOT.2013.2248891.
Address for correspondence
University of Ontario Institute of Technology
2000 Simcoe Street North, Oshawa, Ontario, Canada
Email: c.mcgregor@ieee.org

